Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-3000Fax+1 615-936-0605
Education & Training
Vanderbilt University Medical Center1985 - 1986- University of Texas Health Science Center at Dallas1983 - 1985
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1980 - 1983
University of Illinois College of MedicineClass of 1980
Certifications & Licensure
IL State Medical License 1981 - 2026
TN State Medical License 1986 - 2026
KY State Medical License 1999 - 2025
AL State Medical License 2020 - 2020
FL State Medical License 2012 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Effect of Intense vs. Standard Hypertension Management on Nighttime Blood Pressure - an Ancillary Study to SPRINT Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial.Melisa Cooper, David Z I Cherney, Tom H Greene, Hiddo J L Heerspink, Meg Jardine
Journal of the American Society of Nephrology. 2024-11-01 - 1 citationsA meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.Hiddo J L Heerspink, Devin Eddington, Juhi Chaudhari, Raymond Estacio, Enyu Imai
Kidney International. 2024-10-01 - Association between Acute Declines in eGFR during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.Elaine Ku, Hocine Tighiouart, Charles E McCulloch, Lesley A Inker, Ogechi M Adingwupu
Journal of the American Society of Nephrology. 2024-10-01
Press Mentions
FDA Panel Backs Entresto, Spironolactone for Broader HF UseDecember 16th, 2020- Effects of 2 Drug Classes Compared in Advanced Chronic Kidney DiseaseDecember 10th, 2020
Study Addresses Barriers to Kidney Disease Screening Among Black AmericansMarch 16th, 2018- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
